Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis

American Heart Journal

Volumn 190, Issue , 2017, Pages 135-139

  Bagai, Akshay ^a   Alexander, Karen P ^b   Berger, Jeffrey S ^c   Senior, Roxy ^d,e,f   Sajeev, Chakkanalil ^g   Pracon, Radoslaw ^h   Mavromatis, Kreton ⁱ   Lopez Sendón, Jose Luis ^j   Gosselin, Gilbert ^k   Diaz, Ariel ^l   Perna, Gian ^m   Drozdz, Jarozlaw ⁿ   Humen, Dennis ^o   Petrauskiene, Birute ^p   Cheema, Asim N ^a   Phaneuf, Denis ^q   Banerjee, Subhash ^r   Miller, Todd D ^s   Kedev, Sasko ^t   Schuchlenz, Herwig ^u   Stone, Gregg W ^v   Goodman, Shaun G ^a,w   Mahaffey, Kenneth W ^x   Jaffe, Allan S ^s   Rosenberg, Yves D ^y   Bangalore, Sripal ^c   Newby, L Kristin ^b   Maron, David J ^x   Hochman, Judith S ^c   Chaitman, Bernard R ^z   more..

^a ST MICHAEL'S HOSPITAL   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e NORTHWICK PARK HOSPITAL   (United Kingdom)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g GOVERNMENT MEDICAL COLLEGE   (India)

^h INSTITUTE OF CARDIOLOGY   (Poland)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^k MONTREAL HEART INSTITUTE   (Canada)

^l UNIVERSITÉ DE MONTRÉAL   (Canada)

^m OSPEDALI RIUNITI   (Italy)

ⁿ MEDICAL UNIVERSITY OF LODZ   (Poland)

^o LONDON HEALTH SCIENCES CENTRE   (Canada)

^p VILNIUS UNIVERSITY   (Lithuania)

^q Department of Cardiology   (Canada)

^r UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^s MAYO CLINIC   (United States)

^t University Cardiology Clinic   (Macedonia)

^u LHK Graz Sued/West ^*  (Austria)

^v Department of Medicine   (United States)

^w CANADIAN HEART RESEARCH CENTRE   (Canada)

^x STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^z SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ARTICLE; ASSAY; CARDIAC TROPONIN 1 CLIA KIT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONSENSUS DEVELOPMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; HOSPITAL LABORATORY; HUMAN; IMMUNOASSAY ANALYZER; LABORATORY TEST; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; BLOOD; MULTICENTER STUDY; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDY; UNITED STATES;

BIOMARKERS; HUMANS; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; TROPONIN; UNITED STATES;

EID: 85021251454     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2017.04.016     Document Type: Article

References (16)

1. Alpert, J.S., Thygesen, K., Antman, E., et al. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000), 959–969.
2. Pulkki, K., Suvisaari, J., Collinson, P., et al. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across europe. The cardiac marker guideline uptake in Europe (CARMAGUE) study. Clin Chem Lab Med 47 (2009), 227–234.
3. Leonardi, S., Armstrong, P.W., Schulte, P.J., et al. Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review. Eur Heart J 34 (2013), 894d–902d.
4. Collinson, P.O., Heung, Y.M., Gaze, D., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 58 (2012), 219–225.
5. Cardinaels, E.P., Mingels, A.M., Jacobs, L.H., et al. A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead. Clin Chem Lab Med 50 (2012), 791–806.
6. Wildi, K., Gimenez, M.R., Twerenbold, R., et al. Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation 131 (2015), 2032–2040.
7. Apple, F.S., Ler, R., Murakami, M.M., Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58 (2012), 1574–1581.
8. Collinson, P., Hammerer-Lercher, A., Suvisaari, J., et al. How well do laboratories adhere to recommended clinical guidelines for the management of myocardial infarction: the cardiac marker guidelines uptake in europe study (CARMAGUE). Clin Chem 62 (2016), 1264–1271.
9. Mills, N.L., Lee, K.K., McAllister, D.A., et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ, 344, 2012, e1533.
10. Bohula May, E.A., Bonaca, M.P., Jarolim, P., et al. Prognostic performance of a high-sensitivity cardiac troponin i assay in patients with non–ST-elevation acute coronary syndrome. Clin Chem 60 (2014), 158–164.
11. Kontos, M.C., Shah, R., Fritz, L.M., et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 43 (2004), 958–965.
12. Wallentin, L., Lindholm, D., Siegbahn, A., et al. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non–ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 129 (2014), 293–303.
13. Giannitsis, E., Wallentin, L., James, S.K., et al. Outcomes after planned invasive or conservative treatment strategy in patients with non–ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: a Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy. Eur Heart J, 2016.
14. Westwood, M., van Asselt, T., Ramaekers, B., et al. High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis. Health Technol Assess 19 (2015), 1–234.
15. Hicks, K.A., Tcheng, J.E., Bozkurt, B., et al. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association task force on clinical data standards (writing committee to develop cardiovascular endpoints data standards). Circulation 132 (2015), 302–361.
16. Jaffe, A.S., Apple, F.S., Morrow, D.A., et al. Being rational about (im)precision: a statement from the biochemistry subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation task force for the definition of myocardial infarction. Clin Chem 56 (2010), 941–943.